AGN-229666 for the Treatment of Allergic Conjunctivitis

Study Identifier
229666-002
CT.gov Identifier
NCT01754766
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Conjunctivitis
    • Study Drug
  • AGN-229666
    • Phase
    Phase 2
    Sex
    Female & Male
    Age
    20+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Japanese patients living in Japan with a history of allergic conjunctivitis * Willing to discontinue wearing contact lenses during the study period
    Exclusion Criteria:
    * Use of nicotine products during the study period * Presence of active eye infection (bacterial, viral, or fungal) * History of an ocular herpetic infection * Eye surgery intervention within 3 months and/or a history of refractive surgery within the past 6 months

    Protocol Summary

    This study will evaluate the safety and efficacy of AGN-229666 for the treatment of allergic conjunctivitis.

    Study Locations

    Location
    Status
    Location
    Tokyo, Japan
    Status
    Not applicable